The adipose tissue renin-angiotensin system and metabolic disorders: a review of molecular mechanisms

References

• Achard V, Boullu-Ciocca S, Desbriere R, Nguyen G, Grino M. 2007. Renin receptor expression in human adipose tissue. Am J Physiol Regul Integr Comp Physiol 292:R274–R282.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr; International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. 2009. Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 120:1640–1645.
   PubMed Web of Science ®Google Scholar
• Alligier M, Meugnier E, Debard C, Lambert-Porcheron S, Chanseaume E, Sothier M, Loizon E, Hssain AA, Brozek J, Scoazec JY, Morio B, Vidal H, Laville M. 2012. Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J Clin Endocrinol Metab 97:E183–E192.
   PubMed Web of Science ®Google Scholar
• Araki K, Masaki T, Katsuragi I, Tanaka K, Kakuma T, Yoshimatsu H. 2006. Telmisartan prevents obesity and increases the expression of uncoupling protein 1 in diet-induced obese mice. Hypertension 48:51–57.
   PubMed Web of Science ®Google Scholar
• Asamizu S, Urakaze M, Kobashi C, Ishiki M, Norel Din AK, Fujisaka S, Kanatani Y, Bukahari A, Senda S, Suzuki H, Yamazaki Y, Iwata M, Usui I, Yamazaki K, Ogawa H, Ogawa H, Kobayashi M, Tobe K. 2009. Angiotensin II enhances the increase in monocyte chemoattractant protein-1 production induced by tumor necrosis factor-{alpha} from 3T3-L1 preadipocytes. J Endocrinol 202:199–205.
   Google Scholar
• Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. 1995. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest 95:948–953.
   PubMed Web of Science ®Google Scholar
• Boschmann M, Ringel J, Klaus S, Sharma AM. 2001. Metabolic and hemodynamic response of adipose tissue to angiotensin II. Obes Res 9:486–491.
   PubMedGoogle Scholar
• Boustany CM, Bharadwaj K, Daugherty A, Brown DR, Randall DC, Cassis LA. 2004. Activation of the systemic and adipose renin-angiotensin system in rats with diet-induced obesity and hypertension. Am J Physiol Regul Integr Comp Physiol 287:R943–R949.
   PubMed Web of Science ®Google Scholar
• Brink M, Wellen J, Delafontaine P. 1996. Angiotensin II causes weight loss and decreases circulating insulin-like growth factor I in rats through a pressor-independent mechanism. J Clin Invest 97:2509–2516.
   PubMed Web of Science ®Google Scholar
• Brücher R, Cifuentes M, Acuña MJ, Albala C, Rojas CV. 2007. Larger anti-adipogenic effect of angiotensin II on omental preadipose cells of obese humans. Obesity (Silver Spring) 15:1643–1646.
   PubMedGoogle Scholar
• Cassis L, Helton M, English V, Burke G. 2002. Angiotensin II regulates oxygen consumption. Am J Physiol Regul Integr Comp Physiol 282:R445–R453.
   PubMed Web of Science ®Google Scholar
• Cassis LA, Marshall DE, Fettinger MJ, Rosenbluth B, Lodder RA. 1998. Mechanisms contributing to angiotensin II regulation of body weight. Am J Physiol 274:E867–E876.
   Google Scholar
• Castrop H, Höcherl K, Kurtz A, Schweda F, Todorov V, Wagner C. 2010. Physiology of kidney renin. Physiol Rev 90:607–673.
   PubMed Web of Science ®Google Scholar
• Cole BK, Keller SR, Wu R, Carter JD, Nadler JL, Nunemaker CS. 2010. Valsartan protects pancreatic islets and adipose tissue from the inflammatory and metabolic consequences of a high-fat diet in mice. Hypertension 55:715–721.
   PubMed Web of Science ®Google Scholar
• Crandall DL, Armellino DC, Busler DE, McHendry-Rinde B, Kral JG. 1999. Angiotensin II receptors in human preadipocytes: role in cell cycle regulation. Endocrinology 140:154–158.
   Google Scholar
• Crandall DL, Herzlinger HE, Saunders BD, Armellino DC, Kral JG. 1994. Distribution of angiotensin II receptors in rat and human adipocytes. J Lipid Res 35:1378–1385.
   PubMed Web of Science ®Google Scholar
• Danforth E Jr. 2000. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 26:13.
   PubMed Web of Science ®Google Scholar
• de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. 2000. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415–472.
   PubMed Web of Science ®Google Scholar
• de Kloet AD, Krause EG, Kim DH, Sakai RR, Seeley RJ, Woods SC. 2009. The effect of angiotensin-converting enzyme inhibition using captopril on energy balance and glucose homeostasis. Endocrinology 150:4114–4123.
   Google Scholar
• De Kloet AD, Krause EG, Scott KA, Foster MT, Herman JP, Sakai RR, Seeley RJ, Woods SC. 2011. Central angiotensin-II has catabolic action at white and brown adipose tissue. Am J Physiol Endocrinol Metab 301:E1081–1091.
   Google Scholar
• Demaegdt H, Gard P, De Backer JP, Lukaszuk A, Szemenyei E, Tóth G, Tourwé D, Vauquelin G. 2011. Binding of “AT4 receptor” ligands to insulin regulated aminopeptidase (IRAP) in intact Chinese hamster ovary cells. Mol Cell Endocrinol 339:34–44.
   Google Scholar
• Dickson ME, Zimmerman MB, Rahmouni K, Sigmund CD. 2007. The -20 and -217 promoter variants dominate differential angiotensinogen haplotype regulation in angiotensinogen-expressing cells. Hypertension 49:631–639.
   Google Scholar
• Einstein FH, Fishman S, Bauman J, Thompson RF, Huffman DM, Atzmon G, Barzilai N, Muzumdar RH. 2008. Enhanced activation of a “nutrient-sensing” pathway with age contributes to insulin resistance. FASEB J 22:3450–3457.
   Google Scholar
• Engeli S, Böhnke J, Gorzelniak K, Janke J, Schling P, Bader M, Luft FC, Sharma AM. 2005. Weight loss and the renin-angiotensin-aldosterone system. Hypertension 45:356–362.
   PubMed Web of Science ®Google Scholar
• Engeli S, Boschmann M, Frings P, Beck L, Janke J, Titze J, Luft FC, Heer M, Jordan J. 2006. Influence of salt intake on renin-angiotensin and natriuretic peptide system genes in human adipose tissue. Hypertension 48:1103–1108.
   Google Scholar
• Engeli S, Schling P, Gorzelniak K, Boschmann M, Janke J, Ailhaud G, Teboul M, Massiéra F, Sharma AM. 2003. The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome? Int J Biochem Cell Biol 35:807–825.
   PubMed Web of Science ®Google Scholar
• Faloia E, Gatti C, Camilloni MA, Mariniello B, Sardu C, Garrapa GG, Mantero F, Giacchetti G. 2002. Comparison of circulating and local adipose tissue renin-angiotensin system in normotensive and hypertensive obese subjects. J Endocrinol Invest 25:309–314.
   PubMed Web of Science ®Google Scholar
• Ferrario CM, Varagic J. 2010. The ANG-(1-7)/ACE2/mas axis in the regulation of nephron function. Am J Physiol Renal Physiol 298:F1297–F1305.
   PubMed Web of Science ®Google Scholar
• Flegal KM, Carroll MD, Ogden CL, Curtin LR. 2010. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303:235–241.
   PubMed Web of Science ®Google Scholar
• Fowler JD, Johnson ND, Haroldson TA, Brintnall JA, Herrera JE, Katz SA, Bernlohr DA. 2009a. Regulated renin release from 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 296:E1383–E1391.
   Google Scholar
• Fowler JD, Krueth SB, Bernlohr DA, Katz SA. 2009b. Renin dynamics in adipose tissue: adipose tissue control of local renin concentrations. Am J Physiol Endocrinol Metab 296:E343–E350.
   Google Scholar
• Frederich RC Jr, Kahn BB, Peach MJ, Flier JS. 1992. Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 19:339–344.
   PubMed Web of Science ®Google Scholar
• Fuentes P, Acuña MJ, Cifuentes M, Rojas CV. 2010. The anti-adipogenic effect of angiotensin II on human preadipose cells involves ERK1,2 activation and PPARG phosphorylation. J Endocrinol 206:75–83.
   PubMedGoogle Scholar
• George AJ, Thomas WG, Hannan RD. 2010. The renin-angiotensin system and cancer: old dog, new tricks. Nat Rev Cancer 10:745–759.
   PubMed Web of Science ®Google Scholar
• Giani JF, Mayer MA, Muñoz MC, Silberman EA, Höcht C, Taira CA, Gironacci MM, Turyn D, Dominici FP. 2009. Chronic infusion of angiotensin-(1-7) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am J Physiol Endocrinol Metab 296:E262–E271.
   PubMed Web of Science ®Google Scholar
• Goossens GH, Blaak EE, Arner P, Saris WH, van Baak MA. 2007a. Angiotensin II: a hormone that affects lipid metabolism in adipose tissue. Int J Obes (Lond) 31:382–384.
   Google Scholar
• Goossens GH, Jocken JW, Blaak EE, Schiffers PM, Saris WH, van Baak MA. 2007b. Endocrine role of the renin-angiotensin system in human adipose tissue and muscle: effect of beta-adrenergic stimulation. Hypertension 49:542–547.
   Google Scholar
• Gorzelniak K, Engeli S, Janke J, Luft FC, Sharma AM. 2002. Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension. J Hypertens 20:965–973.
   PubMed Web of Science ®Google Scholar
• Gratze P, Boschmann M, Dechend R, Qadri F, Malchow J, Graeske S, Engeli S, Janke J, Springer J, Contrepas A, Plehm R, Klaus S, Nguyen G, Luft FC, Muller DN. 2009. Energy metabolism in human renin-gene transgenic rats: does renin contribute to obesity? Hypertension 53:516–523.
   PubMed Web of Science ®Google Scholar
• Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. 2010. The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab 12:431–442.
   Google Scholar
• Gupte M, Boustany-Kari CM, Bharadwaj K, Police S, Thatcher S, Gong MC, English VL, Cassis LA. 2008. ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. Am J Physiol Regul Integr Comp Physiol 295:R781–R788.
   Google Scholar
• Harte A, McTernan P, Chetty R, Coppack S, Katz J, Smith S, Kumar S. 2005. Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone. Circulation 111:1954–1961.
   PubMed Web of Science ®Google Scholar
• Heimann AS, Favarato MH, Gozzo FC, Rioli V, Carreno FR, Eberlin MN, Ferro ES, Krege JH, Krieger JE. 2005. Ace gene titration in mice uncovers a new mechanism for ace on the control of body weight. Physiol genomics 20:173–182.
   Google Scholar
• Henriksen EJ. 2007. Improvement of insulin sensitivity by antagonism of the renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 293:R974–R980.
   Google Scholar
• Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. 1995. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415.
   PubMed Web of Science ®Google Scholar
• Hunyady L, Catt KJ. 2006. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 20:953–970.
   PubMed Web of Science ®Google Scholar
• Iwai M, Kanno H, Senba I, Nakaoka H, Moritani T, Horiuchi M. 2011. Irbesartan increased PPAR? activity in vivo in white adipose tissue of atherosclerotic mice and improved adipose tissue dysfunction. Biochem Biophys Res Commun 406:123–126.
   Google Scholar
• Iwashita M, Sakoda H, Kushiyama A, Fujishiro M, Ohno H, Nakatsu Y, Fukushima T, Kumamoto S, Tsuchiya Y, Kikuchi T, Kurihara H, Akazawa H, Komuro I, Kamata H, Nishimura F, Asano T. 2012. Valsartan, independently of AT1 receptor or PPAR?, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes. Am J Physiol Endocrinol Metab 302:E286–E296.
   PubMedGoogle Scholar
• Janke J, Engeli S, Gorzelniak K, Luft FC, Sharma AM. 2002. Mature adipocytes inhibit in vitro differentiation of human preadipocytes via angiotensin type 1 receptors. Diabetes 51:1699–1707.
   PubMed Web of Science ®Google Scholar
• Jayasooriya AP, Mathai ML, Walker LL, Begg DP, Denton DA, Cameron-Smith D, Egan GF, McKinley MJ, Rodger PD, Sinclair AJ, Wark JD, Weisinger HS, Jois M, Weisinger RS. 2008. Mice lacking angiotensin-converting enzyme have increased energy expenditure, with reduced fat mass and improved glucose clearance. Proc Natl Acad Sci USA 105:6531–6536.
   PubMed Web of Science ®Google Scholar
• Jones BH, Standridge MK, Moustaid N. 1997a. Angiotensin II increases lipogenesis in 3T3-L1 and human adipose cells. Endocrinology 138:1512–1519.
   PubMed Web of Science ®Google Scholar
• Jones BH, Standridge MK, Taylor JW, Moustaïd N. 1997b. Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 273:R236–R242.
   PubMed Web of Science ®Google Scholar
• Juan CC, Chien Y, Wu LY, Yang WM, Chang CL, Lai YH, Ho PH, Kwok CF, Ho LT. 2005. Angiotensin II enhances insulin sensitivity in vitro and in vivo. Endocrinology 146:2246–2254.
   Google Scholar
• Kalupahana NS, Claycombe KJ, Moustaid-Moussa N. 2011. (n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr 2:304–316.
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Massiera F, Quignard-Boulange A, Ailhaud G, Voy BH, Wasserman DH, Moustaid-Moussa N. 2012a. Overproduction of angiotensinogen from adipose tissue induces adipose inflammation, glucose intolerance, and insulin resistance. Obesity (Silver Spring) 20:48–56.
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Moustaid-Moussa N. 2012. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev 13:136–149.
   PubMed Web of Science ®Google Scholar
• Kalupahana NS, Moustaid-Moussa N, Claycombe KJ. 2012b. Immunity as a link between obesity and insulin resistance. Mol Aspects Med 33:26–34.
   PubMed Web of Science ®Google Scholar
• Karlsson C, Lindell K, Ottosson M, Sjöström L, Carlsson B, Carlsson LM. 1998. Human adipose tissue expresses angiotensinogen and enzymes required for its conversion to angiotensin II. J Clin Endocrinol Metab 83:3925–3929.
   PubMed Web of Science ®Google Scholar
• Kim S, Voy BH, Huang T, Koontz J, Quignard-Boulange A, Hayser P, Harp J, Moustaid-Moussa N. 2005. Angiotensin ii regulates adipocyte metabolism via insulin signaling molecules. Adipocytes 1:239–248.
   Google Scholar
• Kim S, Whelan J, Claycombe K, Reath DB, Moustaid-Moussa N. 2002. Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. J Nutr 132:1135–1140.
   PubMed Web of Science ®Google Scholar
• Kouyama R, Suganami T, Nishida J, Tanaka M, Toyoda T, Kiso M, Chiwata T, Miyamoto Y, Yoshimasa Y, Fukamizu A, Horiuchi M, Hirata Y, Ogawa Y. 2005. Attenuation of diet-induced weight gain and adiposity through increased energy expenditure in mice lacking angiotensin II type 1a receptor. Endocrinology 146:3481–3489.
   PubMed Web of Science ®Google Scholar
• Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O’Brien DA, Smithies O. 1995. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146–148.
   PubMed Web of Science ®Google Scholar
• Kurata A, Nishizawa H, Kihara S, Maeda N, Sonoda M, Okada T, Ohashi K, Hibuse T, Fujita K, Yasui A, Hiuge A, Kumada M, Kuriyama H, Shimomura I, Funahashi T. 2006. Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation. Kidney Int 70:1717–1724.
   PubMed Web of Science ®Google Scholar
• Lagou V, Manios Y, Moran CN, Bailey ME, Grammatikaki E, Oikonomou E, Ioannou E, Moschonis G, Wilson RH, Pitsiladis YP. 2007. Developmental changes in adiposity in toddlers and preschoolers in the GENESIS study and associations with the ACE I/D polymorphism. Int J Obes (Lond) 31:1052–1060.
   PubMedGoogle Scholar
• Lavoie JL, Sigmund CD. 2003. Minireview: overview of the renin-angiotensin system–an endocrine and paracrine system. Endocrinology 144:2179–2183.
   PubMed Web of Science ®Google Scholar
• Lee RM, Bader M, Alenina N, Santos RA, Gao YJ, Lu C. 2011. Mas receptors in modulating relaxation induced by perivascular adipose tissue. Life Sci 89:467–472.
   PubMed Web of Science ®Google Scholar
• Liu C, Lv XH, Li HX, Cao X, Zhang F, Wang L, Yu M, Yang JK. 2011. Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via mas receptor in adipocytes. Acta diabetol [Epub ahead of print].
   Google Scholar
• Maenhaut N, Van de Voorde J. 2011. Regulation of vascular tone by adipocytes. BMC Med 9:25.
   PubMed Web of Science ®Google Scholar
• Mario EG, Santos SH, Ferreira AV, Bader M, Santos RA, Botion LM. 2011. Angiotensin-(1-7) mas-receptor deficiency decreases peroxisome proliferator-activated receptor gamma expression in adipocytes. Peptides 33:174–177.
   Google Scholar
• Massiéra F, Bloch-Faure M, Ceiler D, Murakami K, Fukamizu A, Gasc JM, Quignard-Boulange A, Negrel R, Ailhaud G, Seydoux J, Meneton P, Teboul M. 2001a. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation. FASEB J 15:2727–2729.
   PubMed Web of Science ®Google Scholar
• Massiéra F, Seydoux J, Geloen A, Quignard-Boulange A, Turban S, Saint-Marc P, Fukamizu A, Negrel R, Ailhaud G, Teboul M. 2001b. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142:5220–5225.
   Google Scholar
• Matsushita K, Wu Y, Okamoto Y, Pratt RE, Dzau VJ. 2006. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes. Hypertension 48:1095–1102.
   Google Scholar
• Miao CY, Li ZY. 2012. The role of perivascular adipose tissue in vascular smooth muscle cell growth. Br J Pharmacol 165:643–658.
   PubMed Web of Science ®Google Scholar
• Muñoz MC, Giani JF, Dominici FP. 2010. Angiotensin-(1-7) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul Pept 161:1–7.
   Google Scholar
• Nguyen Dinh Cat A, Briones AM, Callera GE, Yogi A, He Y, Montezano AC, Touyz RM. 2011. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors. Hypertension 58:479–488.
   PubMed Web of Science ®Google Scholar
• Nyui N, Tamura K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M, Kihara M, Ochiai H, Miyazaki N, Umemura S, Ishii M. 1997. Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats. Hypertension 30:859–867.
   Google Scholar
• Oro C, Qian H, Thomas WG. 2007. Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacol Ther 113:210–226.
   Google Scholar
• Paul M, Poyan Mehr A, Kreutz R. 2006. Physiology of local renin-angiotensin systems. Physiol Rev 86:747–803.
   PubMed Web of Science ®Google Scholar
• Police SB, Thatcher SE, Charnigo R, Daugherty A, Cassis LA. 2009. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arterioscler Thromb Vasc Biol 29:1458–1464.
   PubMed Web of Science ®Google Scholar
• Prat-Larquemin L, Oppert JM, Clément K, Hainault I, Basdevant A, Guy-Grand B, Quignard-Boulangé A. 2004. Adipose angiotensinogen secretion, blood pressure, and AGT M235T polymorphism in obese patients. Obes Res 12:556–561.
   PubMedGoogle Scholar
• Premaratna SD, Manickam E, Begg DP, Rayment DJ, Hafandi A, Jois M, Cameron-Smith D, Weisinger RS. 2012. Angiotensin-converting enzyme inhibition reverses diet-induced obesity, insulin resistance and inflammation in C57BL/6J mice. Int J Obes (Lond) 36:233–243.
   Google Scholar
• Rahmouni K, Mark AL, Haynes WG, Sigmund CD. 2004. Adipose depot-specific modulation of angiotensinogen gene expression in diet-induced obesity. Am J Physiol Endocrinol Metab 286:E891–E895.
   Google Scholar
• Ran J, Hirano T, Adachi M. 2004. Chronic Ang II infusion increases plasma triglyceride level by stimulating hepatic triglyceride production in rats. Am J Physiol Endocrinol Metab 287:E955–E961.
   Web of Science ®Google Scholar
• Riera-Fortuny C, Real JT, Chaves FJ, Morales-Suárez-Varela M, Martínez-Triguero ML, Morillas-Ariño C, Hernández-Mijares A. 2005. The relation between obesity, abdominal fat deposit and the angiotensin-converting enzyme gene I/D polymorphism and its association with coronary heart disease. Int J Obes (Lond) 29:78–84.
   Google Scholar
• Safonova I, Aubert J, Negrel R, Ailhaud G. 1997. Regulation by fatty acids of angiotensinogen gene expression in preadipose cells. Biochem J 322 (Pt 1):235–239.
   Google Scholar
• Santos SH, Braga JF, Mario EG, Pôrto LC, Rodrigues-Machado Mda G, Murari A, Botion LM, Alenina N, Bader M, Santos RA. 2010. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1-7). Arterioscler Thromb Vasc Biol 30:953–961.
   PubMed Web of Science ®Google Scholar
• Santos SH, Fernandes LR, Mario EG, Ferreira AV, Pôrto LC, Alvarez-Leite JI, Botion LM, Bader M, Alenina N, Santos RA. 2008. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes 57:340–347.
   PubMed Web of Science ®Google Scholar
• Sarzani R, Bordicchia M, Marcucci P, Minardi D, Muzzonigro G, Dessì-Fulgheri P, Rappelli A. 2010. Angiotensinogen promoter variants influence gene expression in human kidney and visceral adipose tissue. J Hum Hypertens 24:213–219.
   PubMed Web of Science ®Google Scholar
• Schling P, Schäfer T. 2002. Human adipose tissue cells keep tight control on the angiotensin II levels in their vicinity. J Biol Chem 277:48066–48075.
   PubMed Web of Science ®Google Scholar
• Schmieder RE, Hilgers KF, Schlaich MP, Schmidt BM. 2007. Renin-angiotensin system and cardiovascular risk. Lancet 369:1208–1219.
   PubMed Web of Science ®Google Scholar
• Serazin-Leroy V, Morot M, de Mazancourt P, Giudicelli Y. 2000. Androgen regulation and site specificity of angiotensinogen gene expression and secretion in rat adipocytes. Am J Physiol Endocrinol Metab 279:E1398–E1405.
   Google Scholar
• Serazin V, Dieudonné MN, Morot M, de Mazancourt P, Giudicelli Y. 2004. cAMP-positive regulation of angiotensinogen gene expression and protein secretion in rat adipose tissue. Am J Physiol Endocrinol Metab 286:E434–E438.
   PubMedGoogle Scholar
• Sigmund CD. 2012. Divergent mechanism regulating fluid intake and metabolism by the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol 302:R313–R320.
   Google Scholar
• Skurk T, Lee YM, Hauner H. 2001. Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture. Hypertension 37:1336–1340.
   PubMed Web of Science ®Google Scholar
• Skurk T, van Harmelen V, Blum WF, Hauner H. 2005. Angiotensin II promotes leptin production in cultured human fat cells by an ERK1/2-dependent pathway. Obes Res 13:969–973.
   PubMedGoogle Scholar
• Sloniger JA, Saengsirisuwan V, Diehl CJ, Dokken BB, Lailerd N, Lemieux AM, Kim JS, Henriksen EJ. 2005. Defective insulin signaling in skeletal muscle of the hypertensive TG(mREN2)27 rat. Am J Physiol Endocrinol Metab 288:E1074–E1081.
   PubMed Web of Science ®Google Scholar
• Soltani-Bejnood M, Fletcher S, Morris J, Das S, Voy BH, Moustaid-Moussa N. 2007. Overexpression of renin in the liver impairs glucose tolerance. FASEB J 21 (Meeting Abstract Supplement) A831.
   Google Scholar
• Steckelings UM, Rompe F, Kaschina E, Unger T. 2009. The evolving story of the RAAS in hypertension, diabetes and CV disease: moving from macrovascular to microvascular targets. Fundam Clin Pharmacol 23:693–703.
   PubMed Web of Science ®Google Scholar
• Takahashi N, Li F, Hua K, Deng J, Wang CH, Bowers RR, Bartness TJ, Kim HS, Harp JB. 2007. Increased energy expenditure, dietary fat wasting, and resistance to diet-induced obesity in mice lacking renin. Cell Metab 6:506–512.
   Google Scholar
• Tamura K, Tanimoto K, Ishii M, Murakami K, Fukamizu A. 1993. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation. J Biol Chem 268:15024–15032.
   Google Scholar
• Tamura K, Umemura S, Iwamoto T, Yamaguchi S, Kobayashi S, Takeda K, Tokita Y, Takagi N, Murakami K, Fukamizu A. 1994. Molecular mechanism of adipogenic activation of the angiotensinogen gene. Hypertension 23:364–368.
   Google Scholar
• Tondu AL, Robichon C, Yvan-Charvet L, Donne N, Le Liepvre X, Hajduch E, Ferré P, Dugail I, Dagher G. 2005. Insulin and angiotensin II induce the translocation of scavenger receptor class B, type I from intracellular sites to the plasma membrane of adipocytes. J Biol Chem 280:33536–33540.
   PubMed Web of Science ®Google Scholar
• Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. 1991. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 17:669–677.
   PubMed Web of Science ®Google Scholar
• Tsai YS, Kim HJ, Takahashi N, Kim HS, Hagaman JR, Kim JK, Maeda N. 2004. Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARgamma. J Clin Invest 114:240–249.
   PubMed Web of Science ®Google Scholar
• Tsuchiya K, Yoshimoto T, Hirono Y, Tateno T, Sugiyama T, Hirata Y. 2006. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab 291:E771–E778.
   PubMed Web of Science ®Google Scholar
• Van Harmelen V, Ariapart P, Hoffstedt J, Lundkvist I, Bringman S, Arner P. 2000. Increased adipose angiotensinogen gene expression in human obesity. Obes Res 8:337–341.
   PubMedGoogle Scholar
• Vanderheyden PM. 2009. From angiotensin IV binding site to AT4 receptor. Mol Cell Endocrinol 302:159–166.
   PubMed Web of Science ®Google Scholar
• Vermes E, Ducharme A, Bourassa MG, Lessard M, White M, Tardif JC; Studies Of Left Ventricular Dysfunction. 2003. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 107:1291–1296.
   PubMed Web of Science ®Google Scholar
• Wellen KE, Hotamisligil GS. 2003. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112:1785–1788.
   PubMed Web of Science ®Google Scholar
• Xin W, Kalupahana NS, Booker S, Siriwardhana N, Moustaid-Moussa N. 2011. Silencing of the angiotensinogen gene in adipocytes decreases markers of inflammation, lipogenesis and adipogenesis. FASEB J 25:775.14.
   Google Scholar
• Yamamoto R, Akazawa H, Fujihara H, Ozasa Y, Yasuda N, Ito K, Kudo Y, Qin Y, Ueta Y, Komuro I. 2011. Angiotensin II type 1 receptor signaling regulates feeding behavior through anorexigenic corticotropin-releasing hormone in hypothalamus. J Biol Chem 286:21458–21465.
   Google Scholar
• Ye ZW, Wu XM, Jiang JG. 2010. Knockdown of angiotensinogen by shRNA-mediated RNA interference inhibits human visceral preadipocytes differentiation. Int J Obes (Lond) 34:157–164.
   Google Scholar
• Yiannikouris F, Karounos M, Charnigo R, English VL, Rateri DL, Daugherty A, Cassis LA. 2012. Adipocyte-specific deficiency of angiotensinogen decreases plasma angiotensinogen concentration and systolic blood pressure in mice. Am J Physiol Regul Integr Comp Physiol 302:R244–R251.
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Even P, Bloch-Faure M, Guerre-Millo M, Moustaid-Moussa N, Ferre P, Quignard-Boulange A. 2005. Deletion of the angiotensin type 2 receptor (AT2R) reduces adipose cell size and protects from diet-induced obesity and insulin resistance. Diabetes 54:991–999.
   PubMed Web of Science ®Google Scholar
• Yvan-Charvet L, Massiéra F, Lamandé N, Ailhaud G, Teboul M, Moustaid-Moussa N, Gasc JM, Quignard-Boulangé A. 2009. Deficiency of angiotensin type 2 receptor rescues obesity but not hypertension induced by overexpression of angiotensinogen in adipose tissue. Endocrinology 150:1421–1428.
   Google Scholar
• Yvan-Charvet L, Quignard-Boulangé A. 2011. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney Int 79:162–168.
   PubMed Web of Science ®Google Scholar